Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.

NCT ID: NCT05059093

Last Updated: 2022-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

122 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-25

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Routine fetal ultrasound scan during the second trimester of the pregnancy is a low-cost, noninvasive screening modality that has been proven to lower fetal mortality by up to 20%. One of the critical elements of this exam is the measurement of fetal biometric parameters, which are the head circumference (HC), biparietal diameter (BPD), abdominal circumference (AC), and femur length (FL) measured on biometry standard planes. Those standard planes are taken according to quality standards first described by Salomon et al. and used as the guidelines of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). The biometric parameters extracted from them are essential to diagnose fetal growth restriction (FGR), the world's first cause of perinatal fetal mortality.

Such measurements and image quality assessment are time-consuming tasks that are prone to inter and intraobserver variability depending on the level of skill of the sonographer or the physician performing the exam.

Amniotic fluid (AF) volume assessment is also an essential step in routine screening scans allowing the diagnosis of oligo or hydramnios, both associated with increased fetal mortality rates.

The AF is measured by two main "semi-quantitative" techniques: Amniotic Fluid Index (AFI) and the single deepest pocket (SDP). The latter is more specific as it lowers the overdiagnosis of oligo-amnios without any impact on mortality or morbidity and is easier to perform for the sonographer (only one measurement versus four in the case of the AFI technique). However, AF assessment remains a time-consuming and poorly reproducible task.

Attempts to automate such biometric measurements and AF volume assessment have been made using Artificial Intelligence (AI) and deep learning (DL) tools. Studies showed excellent results "in silico," reaching up to 98 %, 95%, 93 % dice score coefficients for HC, AC, and FL measurements and 89 % DSC for AFI measurements. However, they were all conducted retrospectively without validation on prospectively acquired images.

Reviews and experts have stressed the need for quality peer-reviewed prospective studies to assess AI tools' performance with real-world data. Their performance is expected to be worse and to reflect better their use in the clinical workflow.

This study aims to develop DL models to automate HC, BPD, AC, and FL measurements and AF volume assessment from retrospectively acquired data and test their performances to those of clinicians and experts on prospective real-world fetal US scans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The DL models will be trained, validated, and tested on the retrospectively acquired data first. This data will consist of fetal US images gathered in the participating medical centers after patient-level anonymization. The ground truth for the models will consist of annotations made by radiologists and obstetricians for classification and segmentation purposes. The DL models will be trained to perform the following tasks:

* Detection of the following standard planes as described in the ISUOG guidelines: transthalamic, transventricular, transcerebellar, abdominal, and femoral planes on video loops.
* Image quality scoring according to the ISUOG guidelines of the transthalamic, abdominal and femoral planes.
* Fetal cranium, abdomen, and femur segmentation to measure HC, BPD AC, and FL.
* Detection of AF pockets.
* Segmentation of AF pockets and extraction of pockets depth in order to evaluate the SDP measurement

Physicians will be asked to save additional images and video loops additional to their routine screening in the prospective examinations:

* Eight images: transthalamic, abdominal, and femoral standard planes with and without calipers, SDP with and without calipers.
* Four video loops up to five seconds each:

* A cephalic loop encompassing the transcerebellar, transthalamic, and transventricular planes.
* An abdominal loop going from the four-chamber view of the heart to a cross-section of the kidneys and back.
* A femoral loop with the probe parallel to the sagittal axis of the femur sweeping from side to side.
* A whole amniotic cavity loop, with the probe perpendicular to the ground applying as little pressure as possible on the patient's abdomen, sweeping from the uterine fundus to the cervix, once or twice depending on the volume of the amniotic cavity.

The clinicians performing the exam in "real-time"(RT clinicians), the panel of experts, and the DL models will review the prospective examinations.

The SDP measurement extracted by the AF pocket detection and segmentation models will be directly compared to the value measured by the RT clinicians.

Then, the image quality of planes selected by the RT clinicians and the model will be scored by the panel of experts.

The segmentation task will be evaluated in a tripartite fashion: the model, the RT clinicians, and the panel will all segment the same images.

To assess inter-observer agreement, 10% of the images will be randomly selected and reviewed by two independent reviewers from the panel.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Small for Gestational Age Infant Fetal Growth Restriction Oligohydramnios Polyhydramnios

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Classification and segmentation deep learning models

Models that will be trained on retrospectively acquired data and run on the prospectively acquired data to extract biometric parameters and amniotic volume estimation.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Single or multiple viable pregnancies with a gestational age of 14 weeks or more as dated on a first trimester US scan with the crown-rump length (CRL) measurement or grossly estimated from the last menstrual period (LMP).
* Routine programmed US scan.
* Patient's consent is obtained.
* Patient over 18 years old.

Exclusion Criteria

* Emergency indication for the fetal ultrasound
* Major morphological malformations that do not allow proper measurement of the cranium, abdominal or lower limb, for example, anencephaly, omphalocele, lower limb phocomelia.
* Fetal death.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Ibn Rochd

OTHER

Sponsor Role collaborator

Hassan II University

OTHER

Sponsor Role collaborator

Mohammed VI University Hospital

OTHER

Sponsor Role collaborator

Mohammed V Souissi University

OTHER

Sponsor Role collaborator

Deepecho

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saad Slimani, M.D.

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire Ibn Rochd de Casablanca

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de Radiologie Abou Madi

Casablanca, , Morocco

Site Status

Centre Hospitalier Cheikh Khalifa

Casablanca, , Morocco

Site Status

Centre Hospitalier Universitaire Ibn Rochd

Casablanca, , Morocco

Site Status

Mohamed VI University International Hospital

Casablanca, , Morocco

Site Status

Centre Hospitalier Universitaire Hassan II Fes

Fes, , Morocco

Site Status

Centre Hospitalier Universitaire Mohammed VI Oujda

Oujda, , Morocco

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Morocco

References

Explore related publications, articles, or registry entries linked to this study.

Grytten J, Skau I, Sorensen R, Eskild A. Does the Use of Diagnostic Technology Reduce Fetal Mortality? Health Serv Res. 2018 Dec;53(6):4437-4459. doi: 10.1111/1475-6773.12721. Epub 2018 Jan 19.

Reference Type BACKGROUND
PMID: 29349772 (View on PubMed)

Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, Prefumo F, Toi A, Lee W; ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011 Jan;37(1):116-26. doi: 10.1002/uog.8831. No abstract available.

Reference Type BACKGROUND
PMID: 20842655 (View on PubMed)

Gaudineau A. [Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age]. J Gynecol Obstet Biol Reprod (Paris). 2013 Dec;42(8):895-910. doi: 10.1016/j.jgyn.2013.09.013. Epub 2013 Nov 9. French.

Reference Type BACKGROUND
PMID: 24216305 (View on PubMed)

Sarris I, Ioannou C, Chamberlain P, Ohuma E, Roseman F, Hoch L, Altman DG, Papageorghiou AT; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Intra- and interobserver variability in fetal ultrasound measurements. Ultrasound Obstet Gynecol. 2012 Mar;39(3):266-73. doi: 10.1002/uog.10082.

Reference Type BACKGROUND
PMID: 22535628 (View on PubMed)

Tashfeen K, Hamdi IM. Polyhydramnios as a predictor of adverse pregnancy outcomes. Sultan Qaboos Univ Med J. 2013 Feb;13(1):57-62. doi: 10.12816/0003196. Epub 2013 Feb 27.

Reference Type BACKGROUND
PMID: 23573383 (View on PubMed)

Morris RK, Meller CH, Tamblyn J, Malin GM, Riley RD, Kilby MD, Robson SC, Khan KS. Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG. 2014 May;121(6):686-99. doi: 10.1111/1471-0528.12589. Epub 2014 Feb 7.

Reference Type BACKGROUND
PMID: 24738894 (View on PubMed)

Kehl S, Schelkle A, Thomas A, Puhl A, Meqdad K, Tuschy B, Berlit S, Weiss C, Bayer C, Heimrich J, Dammer U, Raabe E, Winkler M, Faschingbauer F, Beckmann MW, Sutterlin M. Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial. Ultrasound Obstet Gynecol. 2016 Jun;47(6):674-9. doi: 10.1002/uog.14924.

Reference Type BACKGROUND
PMID: 26094600 (View on PubMed)

Sande JA, Ioannou C, Sarris I, Ohuma EO, Papageorghiou AT. Reproducibility of measuring amniotic fluid index and single deepest vertical pool throughout gestation. Prenat Diagn. 2015 May;35(5):434-9. doi: 10.1002/pd.4504. Epub 2015 Mar 28.

Reference Type BACKGROUND
PMID: 25297394 (View on PubMed)

Li Y, Zhang Z, Dai C, Dong Q, Badrigilan S. Accuracy of deep learning for automated detection of pneumonia using chest X-Ray images: A systematic review and meta-analysis. Comput Biol Med. 2020 Aug;123:103898. doi: 10.1016/j.compbiomed.2020.103898. Epub 2020 Jul 14.

Reference Type BACKGROUND
PMID: 32768045 (View on PubMed)

Dhar R, Falcone GJ, Chen Y, Hamzehloo A, Kirsch EP, Noche RB, Roth K, Acosta J, Ruiz A, Phuah CL, Woo D, Gill TM, Sheth KN, Lee JM. Deep Learning for Automated Measurement of Hemorrhage and Perihematomal Edema in Supratentorial Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):648-651. doi: 10.1161/STROKEAHA.119.027657. Epub 2019 Dec 6.

Reference Type BACKGROUND
PMID: 31805845 (View on PubMed)

Sekhar A, Biswas S, Hazra R, Sunaniya AK, Mukherjee A, Yang L. Brain Tumor Classification Using Fine-Tuned GoogLeNet Features and Machine Learning Algorithms: IoMT Enabled CAD System. IEEE J Biomed Health Inform. 2022 Mar;26(3):983-991. doi: 10.1109/JBHI.2021.3100758. Epub 2022 Mar 7.

Reference Type BACKGROUND
PMID: 34324425 (View on PubMed)

Kim HP, Lee SM, Kwon JY, Park Y, Kim KC, Seo JK. Automatic evaluation of fetal head biometry from ultrasound images using machine learning. Physiol Meas. 2019 Jul 1;40(6):065009. doi: 10.1088/1361-6579/ab21ac.

Reference Type BACKGROUND
PMID: 31091515 (View on PubMed)

Sobhaninia Z, Rafiei S, Emami A, Karimi N, Najarian K, Samavi S, Reza Soroushmehr SM. Fetal Ultrasound Image Segmentation for Measuring Biometric Parameters Using Multi-Task Deep Learning. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:6545-6548. doi: 10.1109/EMBC.2019.8856981.

Reference Type BACKGROUND
PMID: 31947341 (View on PubMed)

Cho HC, Sun S, Min Hyun C, Kwon JY, Kim B, Park Y, Seo JK. Automated ultrasound assessment of amniotic fluid index using deep learning. Med Image Anal. 2021 Apr;69:101951. doi: 10.1016/j.media.2020.101951. Epub 2021 Jan 7.

Reference Type BACKGROUND
PMID: 33515982 (View on PubMed)

Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019 Oct 29;17(1):195. doi: 10.1186/s12916-019-1426-2.

Reference Type BACKGROUND
PMID: 31665002 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1268-5186

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fetal Brain Ultrasound
NCT06410391 COMPLETED
WHO Fetal Growth Charts
NCT03755024 UNKNOWN